Category Archives: Health

Latest From Health

Orphan Drug Tax Credit is Crucial to Rare Disease R&D

medical_research

The term “rare disease” may be misleading: to be “rare” a disease must effect fewer than 200,000 people in the U.S., but there are over 7,000 rare diseases that have been identified. Taken together, that means that nearly 30 million Americans suffer from a rare disease or condition.  While innovative therapies have been developed for a variety of these diseases—including Sickle Cell Anemia, Gaucher Disease, and Huntington Disease—too many patients still lack treatment options. Developing Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

Sara Radcliffe: Legislature Shouldn’t Put Hurdles in Way of Cancer Treatments

CLSA

Check out California Life Sciences Association (CLSA) president and chief executive officer Sara Radcliffe’s op-ed that ran in The Sacramento Bee this week. She precisely lays out the concerns and challenges associated with delivering cutting-edge medical therapies to patients.

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

ICYMI: Rep. Hatch Slams Possible Obama Move on Drug Prices

2017Budget

In a hearing held on Thursday to review the Department of Health and Human Services 2017 budget, Senate Finance Committee Chairman Orrin Hatch (R-UT) pressed HHS Secretary Sylvia Burwell on whether or not the Obama Administration is planning to issue an executive order that would allow the government to negotiate drug prices. Read more in the Washington Examiner. Video of Thursday’s hearing can be found on the Senate Finance Committee website.

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

#BIOCEO16 Fireside Chat with Senator Chuck Schumer

CEO2013_115x75_Thumbnail copy

New York Senator Chuck Schumer joined attendees at the 2016 BIO CEO & Investor Conference this afternoon for a fireside chat, moderated by BIO Chairman Ron Cohen, to discuss current political and public policy issues facing the country and the biopharmaceutical industry. The Senator expressed optimism that progress can be made on a bipartisan basis in a number of areas that will be conducive to investment in medical innovation and the well-paying jobs that such Read More >

Events, Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: ,

WSJ: “You can’t make medical progress by punishing medical advances.”

WSJ-Logo

Check out today’s Wall Street Journal Editorial, highlighting why you can’t make medical progress by punishing medical advances. The editorial highlight’s how political attacks on the innovation ecosystem undermine the ability to bring important advances to patients. It notes that new initiatives, such as the Administration’s cancer “moonshot,” will be less likely to find success if short-sighted politicians create “investment uncertainty” that will drive away private capital away from the biopharmaceutical sector.” Read more in Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,